We have heard very little about this study, apart from the fact that IT IS ongoing.
The only (semi) specific data that I can find from IMU ann's goes back to the CR presentation of 07-06-2018. (Ref p. 20).
At that stage it had 3 enrollments out of an intended 48 after commencing 18 months prior (Dec 2016). Interim data is due Dec 2019 - 18 months from date of that ann. Hope they have been able to get a bit of a hurry on.
Time for a bit of an update? I believe LC is (has been) on the US East Coast. Perhaps one is coming.
Also, nowhere have we been given any reasonably comprehensive briefing of the results of the preceding completed P1 study, much less any analysis of their significance. Brief details are tabulated on p. 20 of the above mentioned ann.
II think it is fair to say that we deserve a lot more background info on these Mayo trials than the oft repeated preso diagrams which we have been fed.
- Forums
- ASX - By Stock
- Current OSU/Mayo P2 Her-2 Study (No Chemo)
We have heard very little about this study, apart from the fact...
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $386.7M |
Open | High | Low | Value | Volume |
3.8¢ | 3.9¢ | 3.8¢ | $134.8K | 3.498M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 1738258 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 494405 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 5665336 | 0.018 |
14 | 3997559 | 0.017 |
6 | 2974375 | 0.016 |
10 | 3219799 | 0.015 |
4 | 497500 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 400000 | 2 |
0.020 | 5410946 | 12 |
0.021 | 8494780 | 17 |
0.022 | 8757253 | 13 |
0.023 | 4826614 | 8 |
Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
IMU (ASX) Chart |